Trials / Enrolling By Invitation
Enrolling By InvitationNCT01728402
Pathogenesis of Hematologic Malignancies
Pathogenesis of Acute Leukemia, Lymphoproliferative Disorders, and Myeloproliferative Disorders
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- OHSU Knight Cancer Institute · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The cause of blood and bone marrow cancers is poorly understood; however, most research focuses on how cancer cells grow and develop. Because the causes of these cancers are unknown, current treatments may be unnecessarily harsh and often do not provide a cure. Identifying the causes of blood cancers would allow for the development of treatments that are more likely to provide a cure. To find the causes of blood and bone marrow cancers, we will look for specific cancer cell abnormalities that are responsible for cancer cell growth. We will then look to see if drugs that can reverse these abnormalities can kill cancer cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | blood draw, bone marrow procedure, or tissue biopsy |
Timeline
- Start date
- 2008-09-01
- First posted
- 2012-11-19
- Last updated
- 2026-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01728402. Inclusion in this directory is not an endorsement.